Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation for Oncolytic Virotherapies

      Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation for Oncolytic Virotherapies

      Medical Dialogues Bureau14 Oct 2018 10:16 AM IST
      New Delhi: Themis announced that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max...
      Pfizer announces $3 million grant for ASPIRE Breast Cancer Research

      Pfizer announces $3 million grant for ASPIRE Breast Cancer Research

      Medical Dialogues Bureau14 Oct 2018 9:58 AM IST
      New Delhi: Pfizer Inc. has recently announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast...
      Bristol-Myers to invest in Compugen, collaborate in clinical trials

      Bristol-Myers to invest in Compugen, collaborate in clinical trials

      Medical Dialogues Bureau14 Oct 2018 9:16 AM IST
      TEL AVIV - Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid...
      Lundbeck gets DCGI nod for Brintellix antidepressant, launches in India

      Lundbeck gets DCGI nod for Brintellix antidepressant, launches in India

      Medical Dialogues Bureau13 Oct 2018 12:46 PM IST
      Brintellix, is a novel multimodal antidepressant, which has been specifically designed to inhibit serotonin reuptake and modulate serotonergic...
      Clinical Trial of Sirolimus balloon catheter: Cardiologist invests 60 million dollar in Device maker

      Clinical Trial of Sirolimus balloon catheter: Cardiologist invests 60 million dollar in Device maker

      Medical Dialogues Bureau13 Oct 2018 12:30 PM IST
      HOUSTON: An Indian-American cardiologist and entrepreneur has invested $60 million in a medical company that will support clinical trial on cardiac...
      Zydus Cadila gets tentative USFDA nod for Linagliptin and Metformin Hydrochloride tablets

      Zydus Cadila gets tentative USFDA nod for Linagliptin and Metformin Hydrochloride tablets

      Medical Dialogues Bureau13 Oct 2018 12:26 PM IST
      New Delhi: Drug firm Zydus Cadila Friday said it has received tentative approval from the US health regulator to market Linagliptin and Metformin...
      Abbvie settles Humira patent disputes with Novartis unit

      Abbvie settles Humira patent disputes with Novartis unit

      Medical Dialogues Bureau13 Oct 2018 9:16 AM IST
      Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat...
      Amway appoints Milind Pant as CEO

      Amway appoints Milind Pant as CEO

      Medical Dialogues Bureau13 Oct 2018 9:00 AM IST
      Michigan: Direct selling major Amway Friday announced appointment of Milind Pant, first Indian and non-family individual, as its Chief Executive...
      UP to open 6 pharma parks; gets Rs 5,000-6,000 Crore commitment

      UP to open 6 pharma parks; gets Rs 5,000-6,000 Crore commitment

      Medical Dialogues Bureau12 Oct 2018 2:24 PM IST
      The Uttar Pradesh government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000...
      Aurobindo Pharma gets USFDA nod for infections treatment drug

      Aurobindo Pharma gets USFDA nod for infections treatment drug

      Medical Dialogues Bureau12 Oct 2018 2:23 PM IST
      Drug firm Aurobindo Pharma on Thursday said it has received final nod from the US health regulator for its Azithromycin Oral suspension used for...
      You are man of honour, come with viable plan to pay Daiichi: HC to Shivinder Singh

      You are man of honour, come with viable plan to pay Daiichi: HC to Shivinder Singh

      Medical Dialogues Bureau12 Oct 2018 2:21 PM IST
      New Delhi: The Delhi High Court on Thursday directed former Ranbaxy Laboratories Ltd. promoter Shivinder Singh to pay the money owed to Japanese...
      Tamil Nadu hub for medical tourism : Banwarilal Purohit

      Tamil Nadu hub for medical tourism : Banwarilal Purohit

      Medical Dialogues Bureau12 Oct 2018 2:17 PM IST
      Chennai: Tamil Nadu has always been an important centre for medical diagnosis and treatment serves as a hub for medical tourism in the eastern part of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok